Scancell (LON:SCLP) Stock Crosses Below Two Hundred Day Moving Average – What’s Next?

Scancell Holdings plc (LON:SCLP) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 10.35 ($0.14) and traded as low as GBX 9 ($0.12). Scancell shares last traded at GBX 9.20 ($0.12), with a volume of 119,982 shares traded.

Scancell Trading Down 0.5%

The company’s fifty day simple moving average is GBX 9.28 and its two-hundred day simple moving average is GBX 10.35. The company has a quick ratio of 13.01, a current ratio of 3.42 and a debt-to-equity ratio of -566.79. The company has a market capitalization of £95.29 million, a price-to-earnings ratio of -14.11 and a beta of 0.35.

Scancell Company Profile

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.